Morton's Neuroma: Manipulation Versus Steroid Injection

NCT ID: NCT05707572

Last Updated: 2023-02-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

62 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-09-30

Study Completion Date

2019-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study compares manipulative therapy to steroid injection in the treatment of Morton's Neuroma.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim of this study is to establish whether manipulative therapy is an effective treatment for Morton's neuroma, a nerve entrapment in the foot. Steroid injection is the current gold standard conservative treatment for this condition. Therefore, a subject group shall be compared to a steroid injection intervention group. Outcomes will be compared using visual analogue pain scales -VAS, Foot Function Index questionnaires and algometric pressure threshold testing. An improvement in the manipulation group VAS of 20mm above the injection group shall be considered as the minimum worthwhile change as this has been identified as the minimum clinically important difference in pain between treatment groups in visual analogue pain scales.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Morton Neuroma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

steroid injection

1 injection of 1mL methylprednisolone \[40mg\]with 1 mL 2% lignocaine

Group Type ACTIVE_COMPARATOR

methylprednisolone

Intervention Type DRUG

a single injection of 1 mL methylprednisolone \[40 mg\] and 1 mL 2% lignocaine

manual manipulation

weekly manipulations to the metatarsophalangeal joints of the forefoot for 6 weeks

Group Type EXPERIMENTAL

manual manipulation

Intervention Type PROCEDURE

The lesser MTPJs of the affected foot will be manually manipulated using a high velocity, low amplitude thrust technique.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

methylprednisolone

a single injection of 1 mL methylprednisolone \[40 mg\] and 1 mL 2% lignocaine

Intervention Type DRUG

manual manipulation

The lesser MTPJs of the affected foot will be manually manipulated using a high velocity, low amplitude thrust technique.

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Depo-Medrone with Lidocaine (40mg + 10mg)/ml adjustment

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* clinical diagnosis of morton's neuroma
* over 18 years of age
* presenting VAS score \> 30mm

Exclusion Criteria

* diabetes,
* rheumatoid arthritis
* fibromyalgia.
* Those currently taking Statins or analgesics
* previous neuroma surgery
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Queen Margaret University

OTHER

Sponsor Role collaborator

Dundee Podiatry Clinic

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

David G Cashley, BSc(Hons)Pod

Role: PRINCIPAL_INVESTIGATOR

Queen Margaret University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Podiatry Department NHS Lothian

Edinburgh, Lothian, United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

129586

Identifier Type: REGISTRY

Identifier Source: secondary_id

PDN001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.